Purchase Order HHSF223201510399A
- Not listed
- This is a $77,592.11 firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The order is for the addition of items from Requisition #1168475, with no set-aside designation. Illumina has a history of providing sequencing instruments, reagents, and related services to support genomic research and diagnostics across various federal agencies, including the National Institutes of Health (NIH),...
- This is a $349,282.98 firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the provision of reagent chemistry kits. The delivery order does not have a set-aside designation. Illumina is a leading manufacturer of sequencing instruments and related consumables, and has previously received federal contracts and sub-awards from agencies including the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC),...
- This is a firm fixed price delivery order issued by the Food and Drug Administration (FDA) to Illumina, Inc. for the provision of reagent (chemistry) kits. The award is valued at $324,335.11 and does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis products and services, including various sequencing systems and accompanying reagents and consumables. The company has a history of providing sequencing-related goods and services to support...
- This $146,929.70 firm fixed price delivery order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The award is for the provision of chemistry reagent kits, with no set-aside designation. Illumina has previously received prime federal contracts and sub-grants from agencies such as the NIH, CDC, USDA, and VA to supply their sequencing systems, consumables, and bioinformatics...
- This is a $248,752.36 firm fixed price delivery order contract awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the provision of reagent kits to support the agency's chemistry research and analysis. Illumina has a history of providing sequencing systems, consumables, and support services to various federal agencies including the NIH, CDC, USDA, and...
- This is a $51,612.94 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the procurement of ILLUMINA REAGENT CHEMISTRY KITS. The award does not utilize any set-aside designations. Illumina is a biotechnology company that specializes in genetic sequencing and genomic analysis technologies. The company has been awarded multiple federal contracts and indefinite delivery vehicles (IDVs) from agencies such as the National Institutes of Health (NIH),...
- This is a $48,468.36 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The award is for the provision of Illumina reagent chemistry kits, which support the agency's scientific research and diagnostic applications. The contract does not have a set-aside designation, reflecting Illumina's specialized technological capabilities. This award is part of a larger $45...
- This is a $82,065.92 firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The contract is for the provision of Illumina reagent kits and does not utilize any set-aside designations. Illumina has been awarded several other significant federal contracts, including a $45 million Indefinite Delivery Contract with the U.S. Department of Agriculture (USDA) and a $231,165...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $112,123.62 contract is for the provision of REAGENT (CHEMISTRY) KITS and does not have a set-aside designation. Illumina has previously received prime and sub-contract awards from other federal agencies like the National Institutes of Health, Centers for Disease Control and Prevention,...
- This is a firm fixed-price delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The award, valued at $396,250.61, is for the supply of reagent chemistry kits. The contract does not have a set-aside designation. Through this award, Illumina will provide the FDA with a range of its sequencing systems, reagents, and related consumables to support genomic sequencing and analysis...
This is a $81,345.73 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc. for the supply of reagent kits to support high throughput DNA sequencing. The award does not have a set-aside designation. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided sequencing systems, reagents, and services to support research and diagnostics across various federal agencies including the NIH, CDC, USDA, and VA. This award appears to be part of Illumina's existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up to $3.3 million, to provide reagents and controls for nucleic acid sequencing platforms used by the Naval Medical Research Center.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $81.3k | 8/19/15 |